Klencke Barbara bought ALXO
March 3, 2026 · Form 4 insider transaction
Klencke Barbara bought 700,000 shares of ALX Oncology Holdings Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
700,000
Price
$0.00
Total value
N/A
InsiderKlencke Barbara
RoleOfficer, Director
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 3, 2026
Filing dateMarch 5, 2026
Shares owned after700,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One-fourth of the shares subject to the option vest on February 25, 2027 and 1/48th vest monthly thereafter.